Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Liver cells attempt to shut down as a defense mechanism against cancer, but this strategy is not particularly effective.

But the man’s condition worsened, progressing into cirrhosis and eventually hepatocellular carcinoma, also known as liver ...

Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...

By week three of Dry January, many of us have already fallen off the wagon. The lure of booze on dark winter days is great.

There’s a stigma surrounding liver cancer. Once you tell people you’ve got it, often you sense a slight judgment. “Oh”, you ...

A UC San Diego study links fatty liver disease, exacerbated by diets high in fat and sugar, to increased liver cancer risk.

Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...

The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, ...

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

In a groundbreaking medical achievement in the UK, a 32-year-old woman from Manchester has undergone the country's first ...